
Melanocortin Agonist
PT-141
Bremelanotide MC1R/MC4R Agonist
PT-141 (Bremelanotide) is a synthetic cyclic lactam analogue of alpha-MSH and a structural relative of Melanotan II (MT-2). It acts as a non-selective melanocortin receptor agonist with significant activity at MC1R, MC3R, and MC4R, and has been studied for centrally-mediated neuroendocrine and autonomic effects in preclinical research.
Quantity
10MG
Purity
98%+
FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
Research Information
- Cyclic lactam melanocortin receptor agonist with activity at MC1R, MC3R, MC4R
- Central nervous system-mediated mechanism of action via melanocortin receptors
- Studied for neuroendocrine and autonomic nervous system pathway interactions
- Structural analogue of Melanotan II with modified receptor selectivity profile
- Research applications in reproductive neuroendocrinology and central autonomic biology
Storage Conditions
- Long-term: −20°C lyophilised
- Reconstituted: 4°C, use within 28 days
- Protect from UV light
Safe Handling
- For laboratory research use only
- Handle with standard PPE
Frequently Asked
COMPOUND FAQ
Continue Exploring
RELATED COMPOUNDS


Melanocortin Agonist
MT-2
A synthetic cyclic heptapeptide analogue of α-MSH with high affinity for melanocortin receptors, used extensively in pigmentation and appetite research.

Reconstitution Solution
BAC Water
Sterile water for injection containing 0.9% benzyl alcohol as a bacteriostatic preservative. The standard reconstitution vehicle for research peptide compounds.

COMING SOON
Nootropic Peptide
Semax
A synthetic heptapeptide analogue of ACTH(4-7) developed for research into neuroprotective mechanisms, BDNF expression, and cognitive function pathways.
RESEARCH USE ONLY: PT-141 is sold exclusively for in vitro laboratory research. Not intended for human or animal consumption. Not for clinical or therapeutic use.
